The development of a novel diagnostic assay that utilizes a pseudotyped vesicular stomatitis virus for the detection of neutralizing activity against crimean-congo hemorrhagic fever virus

Yuto Suda, John Chamberlain, Stuart Dowall, Masayuki Saijo, Taisuke Horimoto, Roger Hewson, Masayuki Shimojima

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Crimean-Congo hemorrhagic fever virus is a risk group 4 pathogen, which mandates the use of maximum containment facilities, often termed biosafety level 4 or containment level 4 when working with infectious materials. Diagnostic and research work involving live viruses in such laboratories is timeconsuming and inconvenient, resulting in delays. Herein, we show that serum neutralizing activity against the virus can be measured in low-containment laboratories using a pseudotyped virus.

Original languageEnglish
Pages (from-to)205-208
Number of pages4
JournalJapanese Journal of Infectious Diseases
Volume71
Issue number3
DOIs
Publication statusPublished - 2018

Keywords

  • Biosafety level
  • Crimean-Congo hemorrhagic fever virus
  • Pseudotyped virus

Fingerprint

Dive into the research topics of 'The development of a novel diagnostic assay that utilizes a pseudotyped vesicular stomatitis virus for the detection of neutralizing activity against crimean-congo hemorrhagic fever virus'. Together they form a unique fingerprint.

Cite this